{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:53:51Z","timestamp":1792598031509,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R 01 HL159156"],"award-info":[{"award-number":["R 01 HL159156"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL170224"],"award-info":[{"award-number":["HL170224"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jlr.2026.101164","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:32:18Z","timestamp":1791243138000},"page":"101164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deficiency of the Lipoprotein Lipase Pathway Modifies the Phenotypic Expression of Genetically Determined Lipoprotein(a)"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9834-9494","authenticated-orcid":false,"given":"Sotirios","family":"Tsimikas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica J.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santica M.","family":"Marcovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2026.101164_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis","volume":"71","author":"Tsimikas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jlr.2026.101164_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1172\/JCI113093","article-title":"Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma","volume":"80","author":"Utermann","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jlr.2026.101164_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2026.101164_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.metabol.2012.07.024","article-title":"Lipoprotein(a) metabolism: potential sites for therapeutic targets","volume":"62","author":"Hoover-Plow","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.jlr.2026.101164_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0021-9150(93)90117-D","article-title":"Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population","volume":"101","author":"Werba","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2026.101164_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0021-9150(94)90109-0","article-title":"Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia","volume":"108","author":"Bartens","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2026.101164_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2362.1995.tb01707.x","article-title":"Effect of hypertriglyceridaemia on lipoprotein (a) serum concentrations","volume":"25","author":"Walek","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jlr.2026.101164_bib8","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2009.02.041","volume":"53","author":"Fraley","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jlr.2026.101164_bib9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/clinem\/dgae613","article-title":"Comparison of Patients With Familial Chylomicronemia Syndrome and Multifactorial Chylomicronemia Syndrome","volume":"110","author":"Spagnuolo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jlr.2026.101164_bib10","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI116074","article-title":"Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a)","volume":"90","author":"Sandholzer","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jlr.2026.101164_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-023-00937-4","article-title":"Oxidized phospholipids in cardiovascular disease","volume":"21","author":"Tsimikas","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jlr.2026.101164_bib12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race\/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study","volume":"119","author":"Tsimikas","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.101164_bib13","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1194\/jlr.P027235","article-title":"Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia","volume":"53","author":"Arai","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2026.101164_bib14","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jlr.2026.101164_bib15","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2400201","article-title":"Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jlr.2026.101164_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2507227","article-title":"Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia","volume":"393","author":"Bergmark","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jlr.2026.101164_bib17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/CIRCULATIONAHA.126.080012","article-title":"Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study","volume":"153","author":"Marston","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.101164_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100239","article-title":"Development and validation of an isoform-independent monoclonal antibody-based ELISA for measurement of lipoprotein(a)","volume":"63","author":"Marcovina","year":"2022","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2026.101164_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/clinchem\/42.3.436","article-title":"Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature","volume":"42","author":"Marcovina","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.jlr.2026.101164_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/clinchem\/41.2.246","article-title":"Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a)","volume":"41","author":"Marcovina","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.jlr.2026.101164_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12944-022-01720-z","article-title":"Lp(a), oxidized phospholipids and oxidation-specific epitopes are increased in subjects with keloid formation","volume":"21","author":"Ruder","year":"2022","journal-title":"Lipids in health and disease"},{"key":"10.1016\/j.jlr.2026.101164_bib22","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2023.02.050","article-title":"Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes","volume":"81","author":"Gilliland","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jlr.2026.101164_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacbts.2026.101699","article-title":"A Novel Triglyceride- and Cholesterol-Enriched Lipoprotein(a) Phenotype in Moderate Hypertriglyceridemia: Reversal by ApoC-III Inhibition","author":"Lin","year":"2026","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jlr.2026.101164_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2026.100996","article-title":"A novel immune-isolation method for direct quantification of triglycerides associated with lipoprotein(a)","volume":"67","author":"Lin","year":"2026","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2026.101164_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2026.121866","article-title":"Lipoprotein(a) carries triglyceride species associated with incident cardiovascular disease","volume":"420","author":"Takov","year":"2026","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2026.101164_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/03000605241289294","article-title":"Reduced lipoprotein (a) in patients with severe hypertriglyceridaemia","volume":"52","author":"Jacob","year":"2024","journal-title":"The Journal of international medical research"},{"key":"10.1016\/j.jlr.2026.101164_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) Reduction in Persons with Cardiovascular Disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jlr.2026.101164_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jlr.2026.101164_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2409368","article-title":"Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk","volume":"392","author":"Watts","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jlr.2026.101164_bib30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacl.2026.01.011","article-title":"Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association","volume":"20","author":"Ahmad","year":"2026","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jlr.2026.101164_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2025.03.012","article-title":"Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology","author":"Saadatagah","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jlr.2026.101164_bib32","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1177\/2047487319888054","article-title":"Prevalence of familial chylomicronemia syndrome in a quaternary care center","volume":"27","author":"Pallazola","year":"2020","journal-title":"Eur J Prev Cardiol"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752600194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752600194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:11:25Z","timestamp":1792595485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002222752600194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S002222752600194X"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2026.101164","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of the Lipoprotein Lipase Pathway Modifies the Phenotypic Expression of Genetically Determined Lipoprotein(a)","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2026.101164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101164"}}